Immunoselective pressure and human leukocyte antigen class I antigen machinery defects in microsatellite unstable colorectal cancers.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Cancer Research

• Publication date

  2005-07-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-05-0044PMID 16024646
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Microsatellite instability in colorectal cancer is associated with local lymphocyte infiltration and low frequency of distant metastases

  2005cited by this paper
• Immunogenic peptides generated by frameshift mutations in DNA mismatch repair-deficient cancer cells.

  2004cited by this paper
• Down-regulation of HLA class I antigen processing molecules: an immune escape mechanism of renal cell carcinoma?

  2004cited by this paper
• Identification of an HLA-A0201-Restricted CTL Epitope Generated by a Tumor-Specific Frameshift Mutation in a Coding Microsatellite of the OGT Gene

  2003cited by this paper
• Tumour immunology.

  2003cited by this paper
• Immunoproteasome subunits LMP2 and LMP7 downregulation in primary malignant melanoma lesions: association with lack of spontaneous regression

  2003cited by this paper
• Total loss of MHC class I in colorectal tumors can be explained by two molecular pathways: beta2-microglobulin inactivation in MSI-positive tumors and LMP7/TAP2 downregulation in MSI-negative tumors.

  2003influential reference
• HLA class I defects in malignant lesions: what have we learned?

  2003cited by this paper
• Association of TAP1 downregulation in human primary melanoma lesions with lack of spontaneous regression

  2003cited by this paper
• β2-Microglobulin-Free HLA Class I Heavy Chain Epitope Mimicry by Monoclonal Antibody HC-10-Specific Peptide1

  2003cited by this paper
• Endoplasmic reticulum chaperone-specific monoclonal antibodies for flow cytometry and immunohistochemical staining.

  2003cited by this paper
• Characterization of human lymphocyte antigen class I antigen-processing machinery defects in renal cell carcinoma lesions with special emphasis on transporter-associated with antigen-processing down-regulation.

  2003cited by this paper
• Major histocompatibility complex classI‐restricted antigen processing and presentation

  2002cited by this paper
• Down-Regulation of HLA-A Expression Correlates with a Better Prognosis in Colorectal Cancer Patients

  2002cited by this paper
• Major histocompatibility complex class I-restricted antigen processing and presentation.

  2002cited by this paper
• HLA class I antigen abnormalities and immune escape by malignant cells.

  2002cited by this paper
• A TGFβRII frameshift-mutation-derived CTL epitope recognised by HLA-A2-restricted CD8+ T cells

  2001cited by this paper
• Frameshift peptide‐derived T‐cell epitopes: A source of novel tumor‐specific antigens

  2001cited by this paper
• Immunoselection by T lymphocytes generates repeated MHC class I‐deficient metastatic tumor variants

  2001cited by this paper
• Immune responses to tumour antigens: implications for antigen specific immunotherapy of cancer.

  2001cited by this paper
• Tumor‐infiltrating lymphocytes are a marker for microsatellite instability in colorectal carcinoma

  2001cited by this paper
• Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis

  2001cited by this paper
• A TGF betaRII frameshift-mutation-derived CTL epitope recognised by HLA-A2-restricted CD8+ T cells.

  2001cited by this paper
• Systematic identification of genes with coding microsatellites mutated in DNA mismatch repair‐deficient cancer cells

  2001cited by this paper
• High prevalence of activated intraepithelial cytotoxic T lymphocytes and increased neoplastic cell apoptosis in colorectal carcinomas with microsatellite instability.

  1999cited by this paper
• A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.

  1998cited by this paper
• Mutations of the beta2-microglobulin gene result in a lack of HLA class I molecules on melanoma cells of two patients immunized with MAGE peptides.

  1998cited by this paper
• Why certain antibodies cross-react with HLA-A and HLA-G: epitope mapping of two common MHC class I reagents.

  1998cited by this paper
• Loss of functional beta 2-microglobulin in metastatic melanomas from five patients receiving immunotherapy.

  1996cited by this paper
• Beta 2-microglobulin gene mutations: a study of established colorectal cell lines and fresh tumors.

  1994cited by this paper
• Loss of major histocompatibility complex-encoded transporter associated with antigen presentation (TAP) in colorectal cancer.

  1994cited by this paper
• Resistance to natural killer cell lysis conferred by TAP1/2 genes in human antigen-processing mutant cells.

  1994cited by this paper
• Expression of MHC Class I and Class II Antigens in Colonic Carcinomas

  1989cited by this paper
• Monoclonal antibodies raised against denatured HLA-B locus heavy chains permit biochemical characterization of certain HLA-C locus products.

  1986cited by this paper
• Striking paucity of HLA-A, B, C and beta 2-microglobulin on human neuroblastoma cell lines.

  1983influential reference

• Attenuated Salmonella as a PD-1/PD-L1 SiRNA delivery system for colorectal cancer, hepatocellular carcinoma, and melanoma: A systematic review.

  2026cites this paper
• Liver metastases dampen IL18-driven γδ T cell activity and immunotherapy responsiveness in colorectal cancer.

  2026cites this paper
• Breaking Barriers in CRC Immunotherapy: Cutting-Edge Advances in Personalized Peptide Vaccine Development.

  2025cites this paper
• IFN-γ-driven UBE2D3 upregulation impairs antigen presentation pathways and anti-tumor immunity in pancreatic cancer

  2025cites this paper
• Deficient Mismatch Repair and Microsatellite Instability in Solid Tumors

  2025cites this paper
• Symptomatic pseudoprogression in metastatic colorectal cancer

  2024cites this paper
• Overcoming limitations for antibody-based therapies targeting γδ T (Vg9Vd2) cells

  2024cites this paper
• Peptide-stimulated T cells bypass immune checkpoint inhibitor resistance and eliminate autologous microsatellite instable colorectal cancer cells

  2024cites this paper
• The innate immune landscape of dMMR/MSI cancers predicts outcome of nivolumab treatment: results from the Drug Rediscovery Protocol.

  2024cites this paper
• Peptide-stimulation of autologous T cells reverts immune checkpoint inhibitor resistance of hypermutated colorectal cancer cells

  2024cites this paper
• Mismatch repair protein deficiency and its implications on distant metastasis in colorectal cancer: A comprehensive analysis

  2024cites this paper
• β2-microglobulin expression is associated with aggressive histology, activated tumor immune milieu, and outcome in colon carcinoma.

  2024cites this paper
• Immune checkpoint inhibitors in colorectal cancer: limitation and challenges

  2024cites this paper
• Whither the coloproctologist of the future? Returning to the kindred spirit of the barber-surgeon

  2024cites this paper
• γδ T-cells in human malignancies: insights from single-cell studies and analytical considerations

  2024cites this paper
• Immunotherapy and immunoevasion of colorectal cancer.

  2023cites this paper
• Advances in vaccine development for cancer prevention and treatment in Lynch Syndrome.

  2023cites this paper
• Immune microenvironment and lymph node yield in colorectal cancer

  2023cites this paper
• Integrated analysis of genomic and transcriptomic data for the discovery of splice-associated variants in cancer

  2023cites this paper
• γδ T cells are effectors of immunotherapy in cancers with HLA class I defects

  2023cites this paper
• Distinct mutational processes shape selection of MHC class I and class II mutations across primary and metastatic tumors

  2023cites this paper
• Wnt/β-Catenin Signaling and Resistance to Immune Checkpoint Inhibitors: From Non-Small-Cell Lung Cancer to Other Cancers

  2023cites this paper
• CRC: A Darwinian model of cellular immunoselection

  2022cites this paper
• Cancer Immunology: Immune Escape of Tumors-Expression and Regulation of HLA Class I Molecules and Its Role in Immunotherapies.

  2022cites this paper
• Immunological and Clinico-Molecular Features of Tumor Border Configuration in Colorectal Cancer.

  2022cites this paper
• Effects of Circulating Exosomes on B cells in Head and Neck Squamous Cell Carcinoma

  2022cites this paper
• A simple approach for detecting HLA‐A*02 alleles in archival formalin‐fixed paraffin‐embedded tissue samples and an application example for studying cancer immunoediting

  2022cites this paper
• Associating resistance to immune checkpoint inhibitors with immunological escape in colorectal cancer

  2022cites this paper
• Tumor Antigenicity and a Pre-Existing Adaptive Immune Response in Advanced BRAF Mutant Colorectal Cancers

  2022cites this paper
• Exploring immunotherapy in colorectal cancer

  2022cites this paper
• Clinical, pathological genetics and intratumoral immune milieu of serrated adenocarcinoma of the colon

  2022cites this paper
• Adoptive NK Cell Transfer as a Treatment in Colorectal Cancer Patients: Analyses of Tumour Cell Determinants Correlating With Efficacy In Vitro and In Vivo

  2022cites this paper
• Tumor-infiltrating lymphocytes for adoptive cell therapy: recent advances, challenges, and future directions

  2022cites this paper
• Cancer Neoantigens: Challenges and Future Directions for Prediction, Prioritization, and Validation

  2022influential citation
• Landscape of Immunotherapy Options for Colorectal Cancer: Current Knowledge and Future Perspectives beyond Immune Checkpoint Blockade

  2022cites this paper
• Interferon Gamma, MHC Class I Regulation and Immunotherapy

  2022cites this paper
• MHC heterogeneity and response of metastases to immunotherapy

  2021cites this paper
• Immunotherapy in colorectal cancer.

  2021cites this paper
• Cancer Immunotherapies: From Efficacy to Resistance Mechanisms – Not Only Checkpoint Matters

  2021cites this paper
• From APC to the genetics of hereditary and familial colon cancer syndromes

  2021cites this paper
• Cutaneous metastasis of cecum cancer with MSI-high and BRAFV600E mutation: a case report

  2021cites this paper
• CEG_A_278054 181..197

  2021cites this paper
• Targeting immune checkpoints in gynecologic cancer: updates & perspectives for pathologists

  2021cites this paper
• Intratumor heterogeneity: the hidden barrier to immunotherapy against MSI tumors from the perspective of IFN-γ signaling and tumor-infiltrating lymphocytes

  2021cites this paper
• HLA class I loss in colorectal cancer: implications for immune escape and immunotherapy

  2021cites this paper
• An Update on Immune Checkpoint Therapy for the Treatment of Lynch Syndrome

  2021cites this paper
• Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation

  2021cites this paper
• Perspectives on Immunotherapy of Metastatic Colorectal Cancer

  2021cites this paper
• A Frameshift Peptide Neoantigen-Based Vaccine for Mismatch Repair-Deficient Cancers: A Phase I/IIa Clinical Trial

  2020cites this paper
• Implications of Hereditary Origin on the Immune Phenotype of Mismatch Repair-Deficient Cancers: Systematic Literature Review

  2020cites this paper
• The anti-tumour effect of CD8+ infiltration is associated with Human Leukocyte Antigen Class I expression and tumour proliferation in colorectal cancer

  2020cites this paper
• The interplay between innate and adaptive immunity in cancer shapes the productivity of cancer immunosurveillance

  2020cites this paper
• Differential prognostic impact of CD8+ T cells based on human leucocyte antigen I and PD-L1 expression in microsatellite-unstable gastric cancer

  2020cites this paper
• Relationships Between Immune Landscapes, Genetic Subtypes and Responses to Immunotherapy in Colorectal Cancer

  2020cites this paper
• The expression of TAP1 candidate gene, but not its polymorphism and methylation, is associated with colonic polyp formation in a porcine model of human familial adenomatous polyposis

  2020cites this paper
• A straightforward estimation of cardiac substructure exposure for clinical practice: example of breast rotational intensity modulated radiation therapy

  2020cites this paper
• Expression of human leukocyte antigen class I and β2‐microglobulin in colorectal cancer and its prognostic impact

  2020cites this paper
• The prognostic significance of HLA-A2 expression on somatic cells in patients with left-sided colon and rectal cancers

  2020cites this paper
• RegTools: Integrated analysis of genomic and transcriptomic data for the discovery of splicing variants in cancer

  2020cites this paper
• Role of Human Leukocyte Antigen System as A Predictive Biomarker for Checkpoint-Based Immunotherapy in Cancer Patients

  2020cites this paper
• MHC class I loss in endometrial carcinoma: a potential resistance mechanism to immune checkpoint inhibition

  2020cites this paper
• The Complex Nature of Soft Tissue Sarcomas, Including Retroperitoneal Sarcomas

  2019cites this paper
• Immune checkpoint inhibitors for the treatment of MSI-H/MMR-D colorectal cancer and a perspective on resistance mechanisms

  2019cites this paper
• Is microsatellite instability-high really a favorable prognostic factor for advanced colorectal cancer? A meta-analysis

  2019cites this paper
• Colorectal cancer: A paradigmatic model for cancer immunology and immunotherapy.

  2019cites this paper
• High-dimensional cytometric analysis of colorectal cancer reveals novel mediators of antitumour immunity

  2019cites this paper
• MHC Class-I Loss and Cancer Immune Escape

  2019cites this paper
• MHC/HLA Class I Loss in Cancer Cells.

  2019cites this paper
• Revisiting immune escape in colorectal cancer in the era of immunotherapy

  2019cites this paper
• Confirmation that somatic mutations of beta‐2 microglobulin correlate with a lack of recurrence in a subset of stage II mismatch repair deficient colorectal cancers from the QUASAR trial

  2019cites this paper
• RegTools: Integrated analysis of genomic and transcriptomic data for the discovery of splice-associated variants in cancer

  2018cites this paper
• Colorectal cancer prevention: Immune modulation taking the stage.

  2018cites this paper
• Cancer immunotherapy: broadening the scope of targetable tumours

  2018cites this paper
• Complex pattern of immune evasion in MSI colorectal cancer

  2018influential citation
• Fusobacterium nucleatum Infection in Colorectal Cancer: Linking Inflammation, DNA Mismatch Repair and Genetic and Epigenetic Alterations

  2018cites this paper
• Of Mice, Dogs, Pigs, and Men: Choosing the Appropriate Model for Immuno-Oncology Research.

  2018cites this paper
• Human preprocalcitonin self-antigen generates TAP-dependent and -independent epitopes triggering optimised T-cell responses toward immune-escaped tumours

  2018cites this paper
• The colorectal cancer immune microenvironment and approach to immunotherapies.

  2017cites this paper
• Insights on the HLA-Binding Peptidome in Cancer.

  2017cites this paper
• Spontaneous regression of transverse colon cancer: a case report

  2017cites this paper
• Verbundprojekt „Familiärer Darmkrebs“

  2017cites this paper
• The absence of HLA class I expression in non‐small cell lung cancer correlates with the tumor tissue structure and the pattern of T cell infiltration

  2017cites this paper
• Models for Immune Response and Immune Evasion in MSI Cancer and Lynch Syndrome

  2017cites this paper
• Morphological characterization of colorectal cancers in The Cancer Genome Atlas reveals distinct morphology–molecular associations: clinical and biological implications

  2017cites this paper
• Rejection versus escape: the tumor MHC dilemma

  2017cites this paper
• Introduction to Modern Immunology

  2017cites this paper
• The Immune Biology of Microsatellite-Unstable Cancer.

  2016cites this paper
• Tumor antigens in human cancer control.

  2016cites this paper
• Unraveling the role of preexisting immunity in prostate cancer patients vaccinated with a HER-2/neu hybrid peptide

  2016cites this paper
• Immunological and clinical significance of HLA class I antigen processing machinery component defects in malignant cells.

  2016cites this paper
• Molecular Immunoevasion Strategies Targeting Antigen Processing and Presentation

  2016cites this paper
• Interaction of the host immune system with tumor cells in human papillomavirus associated diseases

  2016cites this paper
• Immunotherapy Progress in Mismatch Repair–Deficient Colorectal Cancer and Future Therapeutic Challenges

  2016influential citation
• Opportunities for immunotherapy in microsatellite instable colorectal cancer

  2016cites this paper
• Low density of FOXP3-positive T cells in normal colonic mucosa is related to the presence of beta2-microglobulin mutations in Lynch syndrome-associated colorectal cancer

  2016cites this paper
• Heterozygote of TAP1 Codon637 decreases susceptibility to HPV infection but increases susceptibility to esophageal cancer among the Kazakh populations

  2015cites this paper
• Microsatellite instability: an update

  2015cites this paper
• Outcome parameters in metastatic colorectal cancer

  2015cites this paper
• Development of a Novel Humanized Single Chain Antibody-Streptococcal Superantigen-Derived Immunotherapy Targeting the 5T4 Oncofetal Antigen

  2015cites this paper
• Multiple Structural and Epigenetic Defects in the Human Leukocyte Antigen Class I Antigen Presentation Pathway in a Recurrent Metastatic Melanoma Following Immunotherapy*

  2015cites this paper